Notice of Thirty first annual general meeting of the Comapny
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Parmax Pharma Limited has issued the notice for its 31st Annual General Meeting scheduled for Tuesday, September 30, 2025 at 3:30 PM IST at its registered office in Rajkot, Gujarat. Three items of business will be tabled: (1) adoption of the audited standalone financial statements for FY ended March 31, 2025, (2) re-appointment of Managing Director Mr. Umang Alkesh Gosalia (DIN: 05153830) who retires by rotation, and (3) appointment of Mr. Samsad Alam Khan (Practicing Company Secretary) as Secretarial Auditor for a first term of five consecutive years from FY 2025-26 to FY 2029-30 at a proposed fee of Rs. 25,000 per annum plus GST and out-of-pocket expenses. Remote e-voting will be open from 9:00 AM on September 27, 2025 to 5:00 PM on September 29, 2025, and the company is using Purva Sharegistry as the e-voting service provider. The BSE script code is 540359 and the CIN is L24231GJ1994PLC023504.
This is a routine AGM notice with no surprises — all three items are standard, non-controversial governance items (financial statement adoption, director re-appointment by rotation, and a new secretarial auditor for the maximum 5-year term). No immediate effect on share price or shareholder value is expected from this filing alone.